Using RNA-seq on pre-treatment CD34+ HSPCs isolated from 25 MDS/AML-MRC patients, we show that RD patients’ BM contains actively cycling cells poised for erythro-myeloid differentiation. This evidence concerns the gene CD34 and acute myeloid leukemia.